전이성 4기 대장암 환자의 한의기반 통합암치료를 통한 증상 호전 증례보고
A Case Report of Symptom Improvement in Stage IV Metastatic Colorectal Cancer Treated with a Korean Medicine-based Integrative Cancer Treatment
3
조회
0
다운로드
3
인용
0
참고문헌
키워드
초록
Objective: This case report shows symptom improvements in stage IV metastatic colorectal cancer treated with a Korean medicine-based integrative cancer treatment (ICT). Methods: A 61-year-old male patient diagnosed with colorectal cancer in November 2017 and metastasis to the lung, peritoneum, and liver in September 2020 was treated with Integrative Cancer Treatment (ICT) for abdominal pain, abdominal discomfort, and anorexia for 1 month. Clinical outcomes were measured with the National Cancer Institute Common Terminology Criteria for Adverse Event (NCI-CTCAE), a numeral rating (NRS), the Eastern Cooperative Oncology Group (ECOG), and the Functional Assessment of Cancer Therapy-General (FACT-G) scales. Results: After treatment, the patient’s abdominal pain was improved from NRS 8 to 1, and the ECOG score of the patient was improved from grade 3 to 2. Integrative Cancer Treatment. Also the score improved on the FACT-G test, and there were no serious side effects of grade 3 or higher according to the NCI-CTCAE. Conclusion: This case study suggests that Korean medicine-based ICT may help to improve abdominal pain and quality of life in patients with metastatic colorectal cancer.
Abstract
Objective: This case report shows symptom improvements in stage IV metastatic colorectal cancer treated with a Korean medicine-based integrative cancer treatment (ICT). Methods: A 61-year-old male patient diagnosed with colorectal cancer in November 2017 and metastasis to the lung, peritoneum, and liver in September 2020 was treated with Integrative Cancer Treatment (ICT) for abdominal pain, abdominal discomfort, and anorexia for 1 month. Clinical outcomes were measured with the National Cancer Institute Common Terminology Criteria for Adverse Event (NCI-CTCAE), a numeral rating (NRS), the Eastern Cooperative Oncology Group (ECOG), and the Functional Assessment of Cancer Therapy-General (FACT-G) scales. Results: After treatment, the patient’s abdominal pain was improved from NRS 8 to 1, and the ECOG score of the patient was improved from grade 3 to 2. Integrative Cancer Treatment. Also the score improved on the FACT-G test, and there were no serious side effects of grade 3 or higher according to the NCI-CTCAE. Conclusion: This case study suggests that Korean medicine-based ICT may help to improve abdominal pain and quality of life in patients with metastatic colorectal cancer.
참고문헌 (19)
- Annual report of cancer statistics in Korea in 2017, "Won YJ", The Korea Central Cancer Registry, National Cancer Center. Ministry of Health and Welfare, ~ (2019)
- Ismaili N, "Treatment of colorectal liver metastases", World J Surg Oncol, 9(1), pp.154~ (2011)
- Leung U, "Colorectal Cancer Liver Metastases and Concurrent Extrahepatic Disease Treated With Resection", Ann Surg, 265(1), pp.158~165 (2017)
- McCulloch M, "Chinese Herbal Medicine and Fluorouracil-Based Chemotherapy for Colorectal Cancer : A Quality-Adjusted Meta-Analysis of Randomized Controlled Trials", Integr Cancer Ther, 15(3), pp.285~307 (2016)
- Zhai XF, "Traditional herbal medicine prevents postoperative recurrence of small hepatocellular carcinoma : A randomized controlled study", Cancer, 124(10), pp.2161~2168 (2018)
- Kim JM, "Integrated Cancer Treatment Roadmap", pp.50115~ (2014), Seohyeonsa
- Karlsen S, "How do cancer patients who die at home differ from those who die elsewhere? J", Palliat Med, 12(4), pp.279~286 (1998)
- Fiorentini G, "Modulated Electro-Hyperthermia as Palliative Treatment for Pancreatic Cancer : A Retrospective Observational Study on 106 Patients", Integr Cancer Ther, 18, pp.1534735419878505~ (2019)
- 고은주, "남성 유방암 폐전이 환자의 폐절제술 후 한의기반 통합암치료로 증상 호전에 대한 증례보고", 대한암한의학회지, 25(1), pp.1~9 (2020), 대한암한의학회[DOI]
- Vinceti M, "Selenium for preventing cancer", Cochrane Database Syst Rev, 1(1), pp.CD005195~ (2018)
- 곽정임, "완화 의학에서의 평가도구", Journal of Hospice and Palliative Care, 12(4), pp.177~193 (2009), 한국호스피스완화의료학회
- "The FACIT Measurement System"[URL]
- "National Cancer institute Common Terminology Criteria for Adverse Events, Version 5.0"[URL]
- 김동현, "대장암의 발병위험요인", Annals of Coloproctolgy, 25(5), pp.356~362 (2009), 대한대장항문학회
- 박효미, "장루 보유한 대장직장암 환자의 삶의 질 영향요인", 임상간호연구, 12(2), pp.123~131 (2006), 병원간호사회
- 유화승, "각종 암환자 69례에 대한 항전이 및 재발억제 효과", 대한한방내과학회지, 23(2), pp.165~173 (2002), 대한한방내과학회
- Kim HG, "CGX, a multiple herbal drug, improves cholestatic liver fibrosis in a bile duct ligation-induced rat model", J Ethnopharmacol, 145(2), pp.653~662 (2013)
- Hu XP, "Antioxidative and hepatoprotective effect of CGX, an herbal medicine, against toxic acute injury in mice", J Ethnopharmacol, 120(1), pp.51~55 (2008)
- 임소이, "만성 골반통에서 미슬토 추출물 (Mistletoe extract)의 피하 투여의 효과", Obstetrics & Gynecology Science, 48(5), pp.1288~1292 (2005), 대한산부인과학회